v3.25.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]    
Revenue
Operating expenses:    
General and administrative (including stock-based compensation) 2,145,151 2,045,849
Depreciation 695 1,582
Research and development (including stock-based compensation) 21,671 23,416
Total operating expenses 2,167,517 2,070,847
Loss from operations (2,167,517) (2,070,847)
Other (income) expense:    
Interest income (62) (652)
Gain (loss) on disposal of assets 972
Interest expense 310,714 159,523
Gain on debt forgiveness (98,245)
Loss on Impairment 9,460,425
Total other expense 212,407 9,620,268
Net (loss) (2,379,924) (11,691,115)
Net (loss) attributable to the noncontrolling interest
Net (loss) applicable to Bion's common stockholders $ (2,379,924) $ (11,691,115)
Net (loss) applicable to Bion's common stockholders per basic common share $ (0.04) $ (0.22)
Net (loss) applicable to Bion's common stockholders per diluted common share $ (0.04) $ (0.22)
Weighted-average number of common shares outstanding:    
Weighted-average number of common shares outstanding, Basic 56,682,167 51,995,654
Weighted-average number of common shares outstanding Diluted 56,682,167 51,995,654